Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Haemonetics acquires Irish medtech company focused on vessel closure for up to $215M
The device at the heart of this transaction is the PerQseal Elite system, a fully bioabsorbable patch for percutaneous vessel closure. The technology has already gained key approvals in Europe.
Cardiovascular health in the United States: Exploring the good, the bad and the ugly
A new comprehensive report detailed the latest stats and trends in hypertension, coronary heart disease, stroke and many other areas of interest. “Progress in cardiovascular health depends on knowing where we stand,” the authors wrote. “To improve, we must measure—not occasionally, but consistently, transparently and with purpose.”
Same-day discharge after PCI for NSTE-ACS is on the rise
Sunil Rao, MD, told Cardiovascular Business that same-day discharge is still relatively rare for these patients, but it appears to be growing more common over time. The COVID-19 pandemic appears to have played a key role in the development of this trend.
Judge blocks Edwards’ JenaValve acquisition—FTC calls it a ‘major win’ for Trump administration
The FTC argued that the $945M deal, first announced in 2024, was "anticompetitive." A federal judge agreed.
The business of cardiology is changing—and cath labs are working to keep up
Financial literacy is no longer optional for physicians. “If you're not financially viable, you can't function,” explained Nirat Beohar, MD. “The business education is probably just as important as learning a new procedure.”

The Harmony pulmonary valve was among the devices involved with the FDA Breakthrough Device Designation program that gained more rapid market clearance. The FDA graph shows cardiovascular devices leading the types of devices involved in the program.

Cardiovascular devices lead FDA Breakthrough Device Designation program

The FDA said cardiovascular devices make up the largest number of technologies accepted into the Breakthrough Devices Program, and several are on the list of the first 50 in the program to gain market clearance.

A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare

VIDEO: How to build a collaborative heart team in structural heart

Brijeshwar Maini, MD, structural heart cardiologist, national and Florida medical director of cardiology, Tenant Health, explains what hospitals need to build a structural heart program and develop a heart-team care collaboration approach.

Cardiologist-backed bill focused on the heart health of South Asian Americans gains momentum

After successfully making it through the House, the new legislation is now headed to the Senate.

Cardiologists, radiologists join American Medical Association to speak out against ACA lawsuit

Yet another lawsuit is taking aim at the Affordable Care Act, and 61 U.S. medical organizations have joined forces to speak out.

Peripheral artery disease patients benefit if they push through discomfort when walking

Researchers said they were surprised to learn that "no pain, no gain" was so accurate for this patient population.

Mitral annular calcium (MAC) does not appear to have a negative effect on long-term transcatheter aortic valve replacement (TAVR) outcomes, according to new research published in the American Journal of Cardiology.

TAVR safe and effective for patients presenting with mitral annular calcium

Researchers from Cleveland Clinic reviewed data from more than 400 patients, presenting their findings in the American Journal of Cardiology.

Interventional cardiologist B. Hadley Wilson, MD, executive vice chair for Atrium Health’s Sanger Heart & Vascular Institute in Charlotte, North Carolina, was selected to serve as ACC president in 2023-2024. Cathleen Biga, MSN, RN, president and CEO of Cardiovascular Management of Illinois, was selected to serve as ACC vice president in 2023-2024. She currently works with more than 100 separate providers throughout the Chicago area.

American College of Cardiology names its next president and vice president

Veteran interventional cardiologist B. Hadley Wilson, MD, will serve as the ACC's next president. He will transition into the new role after ACC.23 in New Orleans.

How patient-reported physical and mental health affect coronary artery disease outcomes

Using patient-reported health scores may be able to help guide treatment decisions for patients presenting with coronary artery disease.

Interventional Cardiology

Haemonetics acquires Irish medtech company focused on vessel closure for up to $215M

Cardiovascular health in the United States: Exploring the good, the bad and the ugly

Same-day discharge after PCI for NSTE-ACS is on the rise

Judge blocks Edwards’ JenaValve acquisition—FTC calls it a ‘major win’ for Trump administration

The business of cardiology is changing—and cath labs are working to keep up